Investors Seek Class Cert. In Touch Screen Co. Securities Suit
Investors accusing biotechnology company Zymergen of misleading them about issues with its flagship technology have asked a California federal court to certify them in their proposed class action against the company....To view the full article, register now.
Already a subscriber? Click here to view full article